ASCO 2022LeukemiaMedical News
The survival rates of B-cell acute lymphoblastic leukemia (B-ALL) have been dramatically improved through relatively new therapies. One such therapy is CD19-directed chimeric antigen receptor T-cell (CART) therapy, which has improved survival rates, particularly in…